Electromagnetic transduction therapy
1 paper2 findings
- 1 lab
- 1 finding against
- Cells1
Outcomes
1Senescence-associated beta-galactosidase
upin human cells1downin human cells1
1 study
Senescence-associated beta-galactosidase
upin human cells1downin human cells1
Electromagnetic transduction therapy increases senescence-associated beta-galactosidase in human cells.
“Contrastingly, 80 mT EMTT increased SA-β-Gal activity unless counteracted by 60% HDFCM.”
Cellsunless counteracted by 60% human dermal fibroblast-conditioned mediumdermal fibroblast80 mT
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)1 Oct 2026
Electromagnetic transduction therapy decreases senescence-associated beta-galactosidase in human cells.
“SA-β-Gal activity, minimal in young cells, was elevated in aged HDFs, but was reduced by 40 mT EMTT with or without HDFCM.”
Cellswith or without human dermal fibroblast-conditioned mediumdermal fibroblast40 mT
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)1 Oct 2026